Publikationsliste 1995-2008

Hukommelsesklinikken blev etableret i 1995, men blev først en selvstændig forskningsenhed i Neurologisk Klinik i 1997. I følgende liste er medtaget afhandlinger og publikationer med tilknytning til klinikken tilbage til 1995. 

Hent den komplette publikationsliste 1995-2008 som pdf-fil

AFHANDLINGER

Disputatser

1.            Waldemar G. Functional brain imaging with SPECT in normal aging and dementia. Methodological, pathophysiological and diagnostic aspects. Cerebrovascular and brain metabolism reviews 1995;7:89-130.Forsvaret den 6. maj 1996 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet

2.            Hasselbalch SG. Quantitation of brain metabolism in humans using PET-FDG: Levels and limitations København: Eget forlag; 2003:1-51. Forsvaret den 25. april 2003 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet.

Ph.d. afhandlinger

1.            Høgh P. Apolipoprotein E (APOE) – genotypens betydning for patofysiologi of sygdomsforløb ved Alzheimer’s sygdom og ved dissemineret sklerose. København: Eget forlag 1999. Forsvaret den 16. februar 2001 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet.

2.            Bech-Azeddine R. The lumbar infusion test in the diagnostic evaluation of adult patients with hydrocephalus. København: Eget forlag 2002. Forsvaret den 4. oktober 2002 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet.

3.            Waldorff FB. Dementia in General Practice: Implementation of a guideline for identification and diagnostic evaluation of dementia København: Månedskrift for praktisk lægegerning; 2003:1-51. ISBN 87-88638-20-0. Forsvaret den 12. maj 2003 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet.

4.            Elberling TV. Cognitive performance, psychiatric symptoms, and health related quality of life in patients with Graves’ disease. Clinical and MR spectroscopic abnormalities. København: Eget forlag; 2004:1-51. Forsvaret den 30. januar, 2004 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet.

5.            Hejl AM. Psychiatric morbidity and prepulse inhibition in patients with cognitive disorders. København: Eget forlag; 2004:1-43. Forsvaret den 10. september 2004 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet.

6.            Vogel A. Kognitive forstyrrelser ved Alzheimers sygdom i tidlig fase. København: Eget forlag; 2005:1-48. Forsvaret den 16. december 2005 ved Københavns Universitet, Det Samfundsvidenskabelige Fakultet.

7.            Simonsen AH. Proteomics based assessment of proteins in the cerebrospinal fluid. Pathogenetic and clinical significance in Alzheimer’s disease. København: Eget forlag; 2007; 1-59. Forsvaret den 23. februar 2007 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet

8.            Ellefsen B. The impact of dementia on oral health: A longitudinal study on dental caries in elderly patients with and without dementia. København: Eget forlag; 2007; 1-64. Forsvaret den 18. juni 2007 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet

9.            Sørensen LV. Everyday life and social relations in home-living patients with mild Alzheimer’s disease and their caregivers: quantitative and qualitative analyses. København: Eget forlag; 2007: 1-50. Forsvaret d 22. august 2007 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet.

10.        Lindquist SG. Autosomal dominant inherited dementia - clinical and molecular genetic aspects. Købehavn: Eget forlag; 2008, 1-40. Forsvaret d. 3. april 2008 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet.

11.        Phung TKT. A nationwide register-based study on epidemiological aspects of dementia. København: Eget forlag; 2008, 1-52. Forsvaret d. 16. december 2008 ved Københavns Universitet, Det Sundhedsvidenskabelige Fakultet.

12.        Dyrby, T. Kvantitativ tractografi: Statistisk modellering af hjernens neurale forbindelser med Diffusion Tensor Imaging (DTI). København: Eget forlag, 2008, 1- . Forsvaret d. 22. oktober 2008 ved Danmarks Tekniske Universitet.

Speciale-afhandlinger

1.            Kjær KH. Den prognostiske betydning af Apolipoprotein E-typing ved Alzheimers sygdom. Danmarks Farmaceutiske Universitet; 1997.

2.            Clemensen L. Neuropsykologisk undersøgelse af præfrontale funktioner ved demensudredning – Analyse af Wisconsin kortsortering og Seks Elementer (modificeret). Københavns Universitet, Institut for Psykologi; 2001.

3.            Sjö NM. Hvornår er isoleret hukommelsessvækkelse hos ældre forstadie til Alzheimers sygdom? En teoretisk og empirisk diskussion. Københavns Universitet, Institut for Psykologi; 2002.

4.            Zoetmulder M. Neuropsykiatriske symptomer ved demens: Analyse af Neuropsychiatric Inventory (NPI) og Behavioral Pathology in Alzheimer’s disease (Behave-AD) ved Alzheimers sygdom. Københavns Universitet, Institut for Psykologi; 2004.

5.            Zornhagen G. Alzheimers sygdom – Genkendelse af emotionelle ansigtsudtryk. Københavns Universitet, Institut for Psykologi; 2005

VIDENSKABELIGE ORIGINAL- OG OVERSIGTSARTIKLER

Førsteforfatter fra Hukommelsesklinikken

1.            Waldemar G, Bruhn P, Kristensen M, Johnsen A, Paulson OB, Lassen NA. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type. A [99mTc]-D,L-HMPAO study. Parkinson/Alzheimer Digest 1995;21-22.

2.            Waldemar G, Paulson OB. Hétérogéneity des patterns de flux sanguin cérébral régional dans la démence de type Alzheimer [Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type]. Alzheimer Actualites 1995;103:6-10.

3.            Bech RA, Juhler M, Waldemar G, Klinken L, Gjerris F. Frontal brain and leptomeningeal biopsy specimans correlated with cerebrospinal fluid outflow resistance and B-wave activity in patients suspected of normal pressure hydrocephalus. Neurosurgery 1997;40:497-502.

4.            Waldemar G. Demens. Ugeskrift for Læger 1997;159:2987-2989.

5.            5. Waldemar G, Høgh P, Paulson OB. Functional brain imaging with SPECT in the diagnosis of Alzheimer's disease. International Psychogeriatrics 1997 (Supl. 1);9:223-227.

6.            Bech RA, Waldemar G, Gjerris F, Klinken L, Juhler M. Shunting effects in patients with idiopathic normal pressure hydrocephalus. Correlation with cerebral and leptomeningeal biopsy findings. Acta Neurochirurgica 1999;141:633-639.

7.            Høgh P, Waldemar G, Knudsen GM, Bruhn P, Mortensen H, Wildschiøtz G, Paulson OB. A multidisciplinary memory clinic in a neurological setting: Diagnostic evaluation of 400 consecutive patients. European Journal of Neurology 1999;6:279-288.

8.            Bech RA, Jespersen B, Gjerris F. Short Review of Hydrocephalus: Classification, Investigation, Treatment and Prognosis with Special Relation to Normal-pressure Hydrocephalus. Panarabian Journal of Neurosurgery 1999;3:1-9.

9.            Høgh P, Oturai A, Schreiber K, Blinkenberg M, Jørgensen OS, Ryder L, Paulson OB,  Sørensen PS, Knudsen GM. Apolipoprotein E and multiple sclerosis: Impact of the epsilon-4 allele on susceptibility, clinical type and progression rate. Multiple sclerosis 2000;6:226-230.

10.        Waldemar G. Functional brain imaging with SPECT in the diagnosis of Alzheimer’s disease. Neuroscience News 2000.

11.        Waldemar G, Dubois B, Emre M, Scheltens P, Tariska P, Rossor M. Diagnosis and management of Alzheimer’s disease and related disorders: The role of neurologists in Europe. European Journal of Neurology 2000;7:133-144.

12.        Waldemar G. Secondary dementias. Dementia Reviews 2000;2:2-5.  

13.        Høgh P, Knudsen GM, Jørgensen OS, Paulson OB, Waldemar G. SPECT and Apolipoprotein E in Alzheimer’s disease: Impact of the epsilon4-allele on regional cerebral blood flow. Journal of Geriatric Psychiatry and Neurology 2001;14:42-51.

14.        Bech-Azeddine R, Waldemar G, Knudsen GM, Høgh P, Bruhn P, Mortensen H, Wildschiødtz G,  Gjerris F, Paulson OB, Juhler M. Idiopathic normal-pressure hydrocephalus; evaluation and findings in a multidisciplinary memory clinic. European Journal of Neurology 2001;8:601-611.

15.        Waldorf FB, Bülow LB, Malterud K, Waldemar G. Management of dementia in primary health care: The experiences of collaboration between the GP and the district nurse. Family Practice 2001;18:549-552

16.        Waldemar G. Donepezil in the treatment of patients with Alzheimer’s disease. Expert Reviews in Neurotherapeutics 2001;1:11-19.

17.        Høgh P, Smith SJ, Scahill RI, Chan D, Harvey RJ, Fox NC, Rossor MN. Epilepsy presenting as AD: Neuroimaging, electroclinical features, and response to treatment. Neurology 2002;58:298-301.

18.        Waldemar G. Reversible dementias – do they exist ? Practical Neurology 2002;2:138-143.

19.        Waldorf FB, Bülow LB, Malterud K, Waldemar G. Erfaringer fra samarbejdet mellem praktiserende læger og hjemmesygeplejersker. Ugeskrift for Læger 2002;164:3767-3770.

20.        Hejl AM, Høgh P, Waldemar G. Potentially reversible conditions in 1000 consecutive memory clinic patients. Journal of Neurology, Neurosurgery, and Psychiatry 2002;73:390-394.

21.        Elberling TV, Stokholm J, Høgh P, Waldemar G. Diagnostic profile of young and middle-aged memory clinic patients. Neurology 2002;59:1259-1262

22.        Andersen BB, Pakkenberg B. Stereological quantitation in cerebella from people with schizophrenia. Br J Psychiatry 2003;182:354-61.

23.        Andersen BB, Gundersen HJ, Pakkenberg B. Aging of the human cerebellum: a stereological study. J Comp Neurol 2003;466:356-65.

24.        Bech-Azeddine R, Amtoft O, Løgager VB, Juhler M. Lumbar resistance to CSF outflow correlated to patency of the cranial subarachnoid space and clinical outcome of endoscopic third ventriculostomy in obstructive hydrocephalus. Child’s Nerv Syst 2003;19:688-9.

25.        Hasselbalch SG. Neuroreceptor imaging with positron emission tomography in dementia. Review Series Dementia 2003;4:2-7.

26.        Stokholm J, Waldemar G. Frontotemporal demens – ny viden om “Picks sygdom”. Ugeskrift for Læger 2003;165:553-556.

27.        Elberling TV, Danielsen ER, Rasmussen ÅK, Feldt-Rasmussen U, Waldemar G, Thomsen C. Reduced total choline and myo-inositol measured with cerebral MRS in acute thyrotoxic Grave’s disease. Neurology 2003;60:142-145.

28.        Hejl AM, Hørding M, Hasselbalch E, Dam H, Hemmingsen R, Waldemar G. Psychiatric morbidity in a neurology based memory clinic – the impact of systematic psychiatric evaluations. Journal of the American Geriatrics Society 2003;51:1773-1778.

29.        Waldorff FB, Almind G, Mäkela M, Møller S, Waldemar G. Implementation of a guideline for dementia in general practice: A controlled study on the effect of a multifaceted strategy. Scandinavian Journal of Primary Health Care 2003:21:142-147.

30.        Hasselbach SG, Waldemar G. Medikamentel behandling af Alzheimers demens. Rationel Farmakoterapi 2003;Februar: 1-3.

31.        Elberling TV, Waldemar G. Diagnostic profile of young and middle aged memory clinic patients – response to post publication peer review. Neurology 2003; 59.

32.        Andersen BB, Fabricius K, Gundersen HJ, Jelsing J, Stark AK. No change in neuron numbers in the dentate nucleus of patients with schizophrenia estimated with a new stereological method--the smooth fractionator. J Anat 2004;205:313-21.

33.        Andersen BB. Reduction of Purkinje cell volume in cerebellum of alcoholics. Brain Res 2004;1007:10-8.

34.        Johannsen P. Long-term treatment of Alzheimer’s disease. Review. CNS Drugs 2004;18:757-68.

35.        Nielsen JE, Johnsen B, Koefoed P, Scheuer KH, Grønbech-Jensen M, Law I, Krabbe K, Nørremølle A, Eiberg H, Søndergård H, Dam M, Rehfeld JF, Krarup C, Paulson OB, Hasholt L, Sørensen SA. Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. Eur J Neurol 2004; 11:817-24

36.        Nielsen JE, Koefoed P, Kjaergaard S, Neerup Jensen L, Nørremølle A, Hasholt L. Prenatal diagnosis of autosomal dominant hereditary spastic paraplegia (SPG4) using direct mutation detection. Prenatal Diagnosis 2004; 24:363-6.

37.        Waldorff FB, Hermann C. Rationelle beslutninger for den travle praktiserende læge: effekt af kursus i internetbaserede søgninger. Ugeskr Læger 2004;166:2054-7.

38.        Vogel A, Stokholm J, Gade A,  Andersen BB, Hejl AM, Waldemar G. Awareness of deficits in Mild Cognitive Impairment and Alzheimer’s disease: Do MCI patients have impaired insight? Dementia and Geriatric Cognitive Disorders 2004;17:181-187

39.        Hejl AM, Glenthøj B, Mackeprang R, Hemmingsen R, Waldemar G. Prepulse inhibition in patients with Alzheimer’s disease. Neurobiology of Aging 2004;25:1045-1050.

40.        Høgh P, Sjø NM, Gade A, Waldemar G. Temporal lobe hypoperfusion in isolated amnesia with slow onset: A Single photon emission tomography study. Dementia and Geriatric Cognitive Disorders 2004;18:15-23

41.        Elberling TV, Rasmussen ÅK, Feldt-Rasmussen U, Hørding M, Perrild H, Waldemar G. Impaired health-related quality of life in Graves’ disease. A prospective study. European Journal of Endocrinology 2004;151:549-55.

42.        Vogel A, Gade A, Stokholm J, Waldemar G. Semantic memory impairment in the earliest phases of Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders 2005;19:75-81.

43.        Stokholm J, Jakobsen O, Czarna J, Mortensen HV, Waldemar G. Years of severe and isolated amnesia can precede the development of dementia in early-onset Alzheimer’s disease. Neurocase 2005;11:48-55.

44.        Vogel A, Hasselbalch SG, Gade A., Ziebell M, Waldemar G. Cognitive and functional neuroimaging correlates for anosognosia in Mild Cognitive Impairment and Alzheimer’s disease. International Journal of Geriatric Psychiatry 2005;20:238-246.

45.        Stokholm J, Vogel A, Gade A, Waldemar G. The Executive Interview (EXIT25) as a Screening Test for Executive Dysfunction in Patients with Mild Dementia. Journal of the American Geriatric Society 2005, 53:1577-81.

46.        Bech-Azedinne R., Gjerris F., Waldemar G., Czosnyka M., Juhler M. Intraventricular or lumbar infusion test in adult communicating hydrocephalus? Practical consequences and clinical outcome of shunt operation. Acta Neurochirurgica (Wien) 2005; 147 (10): 127-136.

47.        Waldorff FB, Rishoj S, Waldemar G. Identification and diagnostic evaluation of possible dementia in general practice: A prospective study. Scandinavian Journal of Primary Health Care 2005; 23(4): 221-226.

48.        Stokholm, J, Vogel A, Gade A, Waldemar G. Heterogeneity in executive impairment in patients with very mild Alzheimer's disease. Dement.Geriatr.Cogn Disord. 2006, 22, 54-59.

49.        Lindquist SG, Nørremølle A, Hjermind LE, Hasholt L, Nielsen JE. Meiotic CAG repeat instability in Spinocerebellar Ataxia Type 6: Maternally transmitted elongation in a presumed sporadic case. Journal of the Neurological Sciences 2006; 241(1-2): 95-8.

50.        Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease. CNS Drugs 2006; 20: 311-325.

51.        Waldemar, G. 100 år med Alzheimers sygdom. Ugeskr Læger 2006; 40:3399-3401.

52.        Phung TKT, Andersen K. Kessing LV, Waldemar G. Livsstil som risikofaktor for udvikling af demens Ugeskr Læger 2006; 40: 3401-3405.

53.        Lindquist SG, Waldemar G, Nielsen JE. Demens – genetiske aspekter. Ugeskr Læger 2006; 40: 3405-3409.

54.        Hasselbalch SG, Gyldensted C, Sørensen LH, Brændgaard H, Andersen K, Lolk A, Kragh-Sørensen P, Waldemar G. Billediagnostik dev demensuderedning. Ugeskr Læger 2006; 40: 3415-3420

55.        Waldorff FB, Haugbølle NW, Møller HC, Rishøj S, Waldemar G. Hukommelsesproblemer blandt ældre i almen praksis: betydning af pårørendeoplysninger. Ugeskr Læger 2006; 40: 3420-3424.

56.        Johannsen P. Medicinsk behandling af Alzheimers sygdom. Ugeskr Læger 2006; 40: 3424-3429.

57.        Stokholm J, Jakobsen O, Czarna JM, Mortensen HV, Waldemar G. Years of Severe and Isolated Amnesia can Precede the Development of Dementia in Early-onset Alzheimer’s Disease, Dementia - Helix Review Series 2006; 8 (3), 5-11.

58.        Vogel A, Mortensen EL, Hasselbalch SG, Andersen BB, Waldemar G. Patient versus informant reported quality of life in the earliest phases of Alzheimer's disease.

59.        Int J Geriatr Psychiatry 2006; 21:1132-8.

60.        Waldemar G, Phung KT, Burns A, Georges J, Hansen FR, Iliffe S,  Marking C, Rikkert MO, Selmes J, Stoppe G, Sartorius N. Access to diagnostic evaluation and treatment for dementia in Europe. Int J Geriatr Psychiatry 2007; 22(1):47-54.

61.        Hasselbalch SG, Baloyannis S, Denislic M, Dubois B, Oertel W, Rossor M, Tsiskaridze A, Waldemar G. Education and training of European neurologists in dementia. Eur J Neurol. 2007;14(5):505-9.

62.        Ryberg C, Rostrup E, Stegmann MB, Barkhof F, Scheltens P, van Straaten EC, Fazekas F, Schmidt R, Ferro JM, Baezner H, Erkinjuntti T, Jokinen H, Wahlund LO, O'brien J, Basile AM, Pantoni L, Inzitari D, Waldemar G; LADIS study group. Clinical significance of corpus callosum atrophy in a mixed elderly population.Neurobiol Aging. 2007; 28(6):955-63.

63.        Vogel A, Mortensen EL, Gade A, Waldemar G. The Category Cued Recall test in very mild Alzheimer's disease: discriminative validity and correlation with semantic memory functions.Eur J Neurol. 2007; 14(1):102-8.

64.        Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007; 14(1): e1-26.

65.        Vogel A, Elberling TV, Hording M, Dock J, Rasmussen AK, Feldt-Rasmussen U, Perrild H, Waldemar G. Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. Psychoneuroendocrinology. 2007;32(1): 36-43.

66.        Hogh P, Garde E, Mortensen EL, Jorgensen OS, Krabbe K, Waldemar G. The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities. Acta Neurol Scand. 2007; 115(4):248-53.

67.        Hasselbalch SG, Hansen ES, Jakobsen TB, Pinborg LH, Lonborg JH, Bolwig TG. Reduced midbrain-pons serotonin transporter binding in patients with obsessive-compulsive disorder. Acta Psychiatr Scand. 2007; 115(5):388-94.

68.        Phung TK, Andersen BB, Hogh P, Kessing LV, Mortensen PB, Waldemar G. Validity of Dementia Diagnoses in the Danish Hospital Registers.Dement Geriatr Cogn Disord. 2007; 10;24(3):220-228.

69.        Waldemar G.  Neurological letter from... Denmark.Pract Neurol. 2007; 7(4):272-4.

70.        Simonsen AH, McGuire J, Hansson O, Zetterberg H, Podust VN, Davies HA, Waldemar G, Minthon L, Blennow K. Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment. Arch Neurol. 2007; 64(3):366-70.

71.        Simonsen AH, Hansson SF, Ruetschi U, McGuire J, Podust VN, Davies HA, Mehta P, Waldemar G, Zetterberg H, Andreasen N, Wallin A, Blennow K. Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods. Dement Geriatr Cogn Disord. 2007;23(4):246-50.

72.        Simonsen AH, McGuire J, Podust VN, Hagnelius NO, Nilsson TK, Kapaki E, Vassilopoulos D, Waldemar G. A Novel Panel of Cerebrospinal Fluid Biomarkers for the Differential Diagnosis of Alzheimer's Disease versus Normal Aging and Frontotemporal Dementia. Dement Geriatr Cogn Disord. 2007;24(6):434-440.

73.        Høgh P, Teller AS, Hasselbalch S, Waldemar G. Visual Rating and ROI-Based Parametric Analysis of rCBF SPECT in Patients with Mild or Questionable Dementia: A Comparative Study. Dement Geriatr Cogn Disord. 2007;24(6):429-433.

74.        Dyrby TB, Sogaard LV, Parker GJ, Alexander DC, Lind NM, Baare WF, Hay-Schmidt A, Eriksen N, Pakkenberg B, Paulson OB, Jelsing J. Validation of in vitro probabilistic tractography. Neuroimage 2007; 37: 1267-1277

75.        Hasselbalch SG, Madsen K, Svarer C, Pinborg LH, Holm S, Paulson OB, Waldemar G, Knudsen GM. Reduced 5-HT2A receptor binding in patients with mild cognitive impairment. Neurobiol.Aging 2008; 29 (12):1830-1838

76.        Hjermind LE, Nielsen JE. [Hereditary Parkinson disease. The Danish Society of Movement Disorders]. Ugeskr.Laeger 2008; 170 (12):1016

77.        Hjermind LE, Vissing J, Asmus F, Krag T, Lochmuller H, Walter MC, Erdal J, Blake DJ, Nielsen JE. No muscle involvement in myoclonus-dystonia caused by epsilon-sarcoglycan gene mutations. Eur.J.Neurol. 2008; 15 (5):525-529

78.        Lindquist SG, Nielsen JE, Stokholm J, Schwartz M, Batbayli M, Ballegaard M, Erdal J, Krabbe K, Waldemar G. Atypical early-onset Alzheimer's disease caused by the Iranian APP mutation. J.Neurol.Sci. 2008; 268 (1-2):124-130

79.        Lindquist SG, Holm IE, Schwartz M, Law I, Stokholm J, Batbayli M, Waldemar G, Nielsen JE. Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur.J.Neurol. 2008; 15 (4):377-385

80.        Lindquist SG, Hasholt L, Bahl JM, Heegaard NH, Andersen BB, Norremolle A, Stokholm J, Schwartz M, Batbayli M, Laursen H, Pardossi-Piquard R, Chen F, St George-Hyslop P, Waldemar G, Nielsen JE. A novel presenilin 2 mutation (V393M) in early-onset dementia with profound language impairment. Eur.J.Neurol. 2008; 15 (10):1135-1139

81.        Lindquist SG, Braedgaard H, Svenstrup K, Isaacs AM, Nielsen JE. Frontotemporal dementia linked to chromosome 3 (FTD-3)--current concepts and the detection of a previously unknown branch of the Danish FTD-3 family. Eur.J.Neurol. 2008; 15 (7):667-670

82.        Ryberg C, Rostrup E, Sjostrand K, Paulson OB, Barkhof F, Scheltens P, van Straaten EC, Fazekas F, Schmidt R, Erkinjuntti T, Wahlund LO, Basile AM, Pantoni L, Inzitari D, Waldemar G. White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study. AJNR Am.J.Neuroradiol. 2008; 29 (8):1498-1504

83.        Simonsen AH, McGuire J, Podust VN, Davies H, Minthon L, Skoog I, Andreasen N, Wallin A, Waldemar G, Blennow K. Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease. Neurobiol.Aging 2008; 29 (7):961-968

84.        Sorensen LV, Waldorff FB, Waldemar G. Social participation in home-living patients with mild Alzheimer's disease. Arch.Gerontol.Geriatr. 2008; 47 (3):291-301

85.        Sorensen LV, Waldorff FB, Waldemar G. Coping with mild Alzheimer's disease. Dementia 2008; 7:287

86.        Sorensen LV, Waldorff FB, Waldemar G. Early counselling and support for patients with mild Alzheimer's disease and their caregivers: a qualitative study on outcome. Aging Ment.Health 2008; 12 (4):444-450

87.        Vogel A. Subjektive hukommelsesklager hos ældre. Er det tegn på demens? Ugeskr.Laeger 2008; 170 (20):1728-1733

88.        Waldemar G, Hyvarinen M, Josiassen MK, Korner A, Lehto H, Wetterberg P. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease. Int.J.Geriatr.Psychiatry 2008; 23 (9):979-981

89.        Waldorff FB, Rishoj S, Waldemar G. If you don't ask (about memory), they probably won't tell. J.Fam.Pract. 2008; 57 (1):41-44

Medforfatter fra Hukommelsesklinikken

1.            Tedeschi E, Hasselbalch SG, Waldemar G, Juhler M, Høgh P, Garde L, Knudsen LL, Klinken L, Gjerris F, Paulson OB. Heterogenous cerebral glucose metabolism in normal pressure hydrocephalus. Journal of Neurology, Neurosurgery, and Psychiatry 1995; 59:608-615.

2.            Juul R, Gisvold SE, Brubakk AO, Frederiksen TA, Waldemar G, Schmidt JF, Ekman R, Edvinsson L. Alterations in perivascular dilatory neuropeptides (CGRP, SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man. Acta Neurochirurgica (Wien) 1995;132:32-41.

3.            Vraamark T, Waldemar G, Strandgaard S, Paulson OB. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation. Journal of Hypertension 1995;13:755-761.

4.            Tedeschi E, Waldemar G, Gyring J, Gade A, Jensen TS, Paulson OB. Regional cerebral blood flow and neuropsychological performance in a Danish family with X-linked bulbo-spinal neuronopathy. International Journal of Neuroscience 1995;83:59-68.

5.            Vorstrup S, Haase J, Waldemar G. EC-IC bypass in patients with chronic hemodynamic insufficiency. Acta Neurologica Scandinavica 1996 (Suppl. 166):79-81.

6.            Vraamark T, Waldemar G, Edvinsson L, Paulson OB. Differential effects of increasing doses of alpha-trinositol on cerebral blood flow autoregulation. Pharmacology & Toxicology 1997;80:38-43.

7.            Freund LG., Høgh P. Apopleksibehandling. Ugeskrift for Læger 1997;159:2721

8.            Nielsen AS, Waldemar G, Jørgensen OS. Alzheimers sygdom - ætiologi og patogenese. Ugeskrift for Læger 1998;160:3193-3197.

9.            Vraamark T, Waldemar G, Paulson OB. Differential effects of migraine drugs on cerebral blood flow autoregulation. Cephalalgia 1998;18:305-311.

10.        Philipsen M, Rosenbeck-Hansen J, Waldemar G. Adfærdsforstyrrelser på plejehjem. 147 konsekutive henvisninger til et tværfagligt konsulentteam. Ugeskrift for Læger 1999:161;5915-5920.

11.        Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, Kennedy A, Hasselbalch S, Fazio F, Heiss W. Impairment of neocortical metabolism predicts progression in Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders 1999;10:494-504.

12.        Mortensen EL, Høgh P. A gender difference in the association between APOE genotype and cognitive decline in the life span from ages 50 to 80. Neurology 2001;57:89-95.

13.        Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A, Wetterholm AL, Zhang R, Haglund A, Subbiah P, and the Donepezil Nordic Study Group. A 1-year randomized placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001;97:489-495.

14.        Gjerris F, Bech-Azzedine R. peritoneography in the assessment of peritoneal cerebrospinal fluid absorption potential for distal ventriculopertoneal catheter placement: technical case report (peer review comment). Neurosurgery 2001; 49, 1269

15.        Abildstrøm H, Høgh P, Sperling B, Møller JT, Yndgaard S, Rasmussen LS. Cerebral blood flow and cogntive function after coronary surgery. Ann Thorac Surg 2002;73:1174-8

16.        Gerlach C, Aaside CT, Humpherys GW, Gade A, Paulson O, Law I. Brain activity related to integrative processes in visual object recognition: Bottom-up integration and the modulatory influence of stored knowledge. Neurospychologia 2002:40:1254-67.

17.        Gerlach C, Law I, Gade A, Paulson OB. The role of action knowledge in the comprehension of artefacts – a PET study. Neuroimage 2002;15:143-52.

18.        Gjerris F, Bech-Azeddine R. There is no transmantle pressure gradient in communicating or non-communicating hydrocephalus. Neurosurgery 2002;50:773-4.

19.        Winblad B, Waldemar G, Wimo A, Zhang R. A 1-year Randomised placebo-controlled study of donepezil in patients with mild to moderate AD. Reply from the authors. Neurology 2002;58:835-836.

20.        Gydesen S, Brown JM, Brun A, Chakrabarti L, Gade A, Johannsen P, Rossor M, Thusgaard T, Grove A, Yancopoulou D, Spillantini MG, Fisher EM, Collinge J, Sørensen SA. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 2002:26:1585-94.

21.        Hansen ES, Hasselbalch S, Law I, Bolwig TG. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int J Neuropsychopharmacol.2002;5(1):1-10.

22.        Ravnkilde B, Videbech P, Rosenberg R, Gjedde A, Gade A. Putative tests of frontal lobe function. A PET study of brain activation during Stroop’s test and verbal fluency. J Clin Exp Neuropsychol 2002:24:534-47.

23.        Hesse B, Mehlsen J, Boesen F, Schmidt JF, Andersen EB, Waldemar G, Andersen AR, Paulson OB, Vorstrup S. Regulation of CBF in patients with autonomic dysfunction and severe postural hypotension. Clinical Physiology and Functional imaging 2002;22:241-247 

24.        Ravnkilde B, Videbech P, Clemmensen K, Egander A, Rasmussen NA, Gjedde A, Rosenberg R, Gade A. The Danish PET/depression project: cognitive function and regional cerebral blood flow. Acta Psychiatr Scand 2003;108, 32-40.

25.        Wimo A, Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm A-L, Mastey V, Haglund A, Zhang R, Micelli R, Chin W, Subbiah P, and the Donepezil Nordic Study Group. An economic evaluation of donepezil in mild to moderate AD: Results of a one-year, double-blind, randomized trial. Dementia and Geriatric Cognitive Disorders 2003;15:44-54.

26.        Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC Petersen RC, Pearl GS, Ganguly M, Rosa P, Laursen H, Parisi JE, Waldemar G, Quinn NP, Dickson DW, Revesz T. Neurofilament inclusion body disease. A new proteinopathy ? Brain 2003;126:2291-2303.

27.        Frisoni GB, Scheltens P, Galluzzi S, Nobili FM, Fox N, Robert P, Soininen H, Wahlund L-O, Waldemar G, Salmon E. Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: Consensus paper of the European Alzheimer’s Disease Consortium (EADC). Journal of Neurology, Neurosurgery, and Psychiatry 2003; 74:1371-1381.

28.        Adams KH, Pinborg LH, Svarer C, Hasselbalch SG, Holm S, Haugbol S, Madsen K, Frokjaer V, Martiny L, Paulson OB, Knudsen GM. A database of [18]F-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage. 2004;21:1105-13.

29.        Bro F, Waldorff FB. Guidelines - let's take a break and then move forward together! Scand J Prim Health Care 2004; 22:2-5.

30.        Brown J, Gydesen S, Johannsen P, Gade A, Skibinski G, Chakrabarti L, Brun A, Spillantini M, Yancopoulou D, Thusgaard T, Sorensen A, Fisher E, Collinge J. Frontotemporal dementia linked to chromosome 3. Dement Geriatr Cogn Disord 2004;17:274-6.

31.        Crone C, Petersen NT, Nielsen JE, Hansen NL, Nielsen JB. Reciprocal inhibition and corticospinal transmission in the arm and leg in patients with autosomal dominant pure spastic paraparesis (ADPSP). Brain 2004; 127:2693-702. 

32.        Fagerlund B, Mackeprang T, Gade A, Glenthoj BY. Effects of low-dose risperidone and low-dose zuclopenthixol on cognitive functions in first-episode drug-naive schizophrenic patients. CNS Spectr 2004;9:364-74.

33.        Lee H-Y, Xu Y, Huang Y, Ahn A.H, Auburger G.W.J , Pandolfo M, Kwieciski H, Grimes D.A, Lang A.E, Nielsen J.E, Averyanov Y, Servidei S, Friedman A, Van Bogaert P, Abramowicz M.J, Bruno M.K, Sorensen B.F, Tang L, Fu Y-H, Ptá ek L.J. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Human Molecular Genetics 2004; 13:3161-3170.

34.        Norremolle A, Hasholt L, Petersen CB, Eiberg H, Hasselbalch SG, Gideon P, Nielsen JE, Sorensen SA. Mosaicism of the CAG repeat sequence in the Huntington disease gene in a pair of monozygotic twins. Am J Med Genet. 2004;130A:154-9.

35.        Pinborg LH, Adams KH, Yndgaard S, Hasselbalch SG, Holm S, Kristiansen H, Paulson OB, Knudsen GM. [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. J Cereb Blood Flow Metab 2004;24:1037-45.

36.        Reventlow SD, Waldorff FB, Witt K, Knudsen E, Kruse T. Kvalitetssikring af osteoporosediagnostik i et amt. Ugeskr Læger 2004;166:2656-9.

37.        Brainin M, Barnes M, Gilhus NE, Selmaj K, Waldemar G. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces  - revised recommendations. European Journal of Neurology 2004;11:577-81.

38.        Pantoni L, Basile AM, Pracucci G, Asplund K, Bogousslavsky J, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, O’Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D, on behalf of the LADIS Study Group. Impact of age-related cerebral white matter changes on the transition to disability. The LADIS (Leukoarariosis nd DISabilitity in the elderly) Study: Rationale, design, and methodology. Neuroepidemiology 2005;24:51-62.

39.        Stark AK, Pelvig DP, Jørgensen AMB, Andersen BB, Pakkenberg B: measuring    morphological and cellular changes in Alzheimer’s dementia: A review emphasizing stereology. Current Alzheimer Research 2005; 2:447-479.

40.        Skibinski G, Parkinson N, Brown JM, Chakrabarti L, Lloyd, SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini GM, Thusgaard T, Brandner S, Brun A, Rossor MN, Gade A, Johannsen P, Sørensen SA, Gydesen S, Fisher EMC, Collinge J. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nature Genetics 2005; 37, 806 – 808.

41.        Scheuer K.H, Nielsen J.E, Krabbe K, Simonsen C, Koefoed P, Sørensen S.A, Gade A, Paulson O.B, Law I. Reduced regional cerebral blood flow in SPG4 linked Hereditary Spastic Paraplegia. Journal of the Neurological Sciences 2005; 235:23-32.

42.        Ruetschi U, Zetterberg H, Podust V.N, Gottfries J, Li S, Hviid Simonsen A, McGuire J, Karlsson M, Rymo L, Davies H, Minthon L, Blennow K. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Experimental Neurology 2005; 196(2):273-81.

43.        Jørgensen L.M, Nielsen J.E, Ravnborg M. MEP Recruitment Curves in Multiple sclerosis and Hereditary Spastic Paraplegia. Journal of the Neurological Sciences 2005; 237(1-2):25-9

44.        van der Flier, WM, van Straaten ECW, Barkhof F, Verdelho, A, Madureira S, Pantoni L, Inzitari D, Erkinjuntti, T, Crisby M, Waldemar G, Schmidt R., Fazekas, F, Scheltens, P on behalf of the LADIS study group. Small vessel disease and general cognitive function in non-disabled elderly: the LADIS study. Stroke 2005; 36(10):2116-20.

45.        Wahlund LO, Almkvist O, Blennow, Engedahl K, Johansson A, Waldemar G, Wolf H. Evidence-based evaluation of magnetic resonans imaging as a diagnostic tool in dementia workup. Top Magn Reson Imaging 2005; 16: 427-37

46.        Gjedde A, Johannsen P, Cold GE, Østergaard L. Cerebral metabolic response to low blood flow: possible role of cytochrome oxidase inhibition. J Cereb Blood Flow Metab. 2005 25(9):1183-96.

47.        Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, Bolwig TG, Knudsen GM.  Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.Int J Neuropsychopharmacol. 2005 8(3):391-401.

48.        Schmidt EA, Czosnyka Z, Momjian S, Czosnyka M, Bech RA, Pickard JD. Intracranial baroreflex yielding an early Cushing response in human. Acta Neurochir (Suppl) 2005; 95:253-256.

49.        Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugbol S, Frokjaer VG, Holm S, Paulson OB, Knudsen GM. MR-based automatic delineation of volumes of interest in human brain PET images

50.        using probability maps. Neuroimage 2005; 24(4):969-79.

51.        Basile, AM, Pantoni, L, Pracucci, G, Asplund, K, Chabriat, H, Erkinjuntti, T, Fazekas, F, Ferro, JM, Hennerici, M, O'Brien, J, Scheltens, P, Visser, MC, Wahlund, LO, Waldemar, G, Wallin, A, Inzitari, D. Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc.Dis 2006; 21: 315-322.

52.        Czarna JM, Waldemar G, Heegaard, N. Biokemiske markører for Alzheimers sygdom. Ugeskr Læger 2006; 10: 1010-1014.

53.        Hjermind L, Johannsen L, Blau N, Wevers R, Luecking C, Hertz J.M, Friberg L, Regeur L, Nielsen J.E, Sørensen S.A. Dopa-responsive dystonia and juvenile Parkinson’s disease in a patient with GTP cyclohydrolase I deficiency. Movement Disorders 2006; 21(5):679-82.

54.        van Straaten EC, Fazekas F, Rostrup E, Scheltens P, Schmidt R, Pantoni L, Inzitari D, Waldemar G, Erkinjuntti T, Mantyla R, Wahlund LO, Barkhof F. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 2006; 37: 836-840.

55.        Gouw AA, Van Der Flier WM, van Straaten EC, Barkhof F, Ferro JM, Baezner H, Pantoni L, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Fazekas F, Scheltens P. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J.Neurol.2006; 253: 1189-1196.

56.        Madureira S, Verdelho A, Ferro J, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Pantoni L, Salvadori E, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D. Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data. Neuroepidemiology 2006; 27: 101-116.

57.        Pantoni L, Poggesi A, Basile AM, Pracucci G, Barkhof F, Chabriat H, Erkinjuntti T, Ferro JM, Hennerici M, O'Brien J, Schmidt R, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D. Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J.Am.Geriatr.Soc 2006; 54: 1095-1101.

58.        Jonsson L, Eriksdotter JM, Kilander L, Soininen H, Hallikainen M, Waldemar G, Nygaard H, Andreasen N, Winblad B, Wimo A. Determinants of costs of care for patients with Alzheimer's disease. Int.J.Geriatr.Psychiatry 2006;  21: 449-459.

59.        Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Haglund A, Zhang R, Schindler R. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. Dement.Geriatr.Cogn Disord 2006; 21, 353-363.

60.        Jonsson L, Andreasen N, Kilander L, Soininen H, Waldemar G, Nygaard H, Winblad B, Jonhagen ME, Hallikainen M, Wimo A. Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL. Alzheimer Dis.Assoc.Disord 2006; 20: 49-55.

61.        Linde R, Hasselbalch SG, Topp S, Paulson OB, Madsen PL. Global cerebral blood flow and metabolism during acute hyperketonemia in the awake and anesthetized rat.J Cereb Blood Flow Metab. 2006; 26(2):170-80. Erratum in: J Cereb Blood Flow Metab. 2006;26(3):448.

62.        Scheuer KH, Nielsen JE, Krabbe K, Paulson OB, Law I. Motor activation in SPG4-linked hereditary spastic paraplegia. J.Neurol.Sci. 2006; 244: 31-39.

63.        Inzitari D, Simoni M, Pracucci G, Poggesi A, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien J, Barkhof F, Visser MC, Wahlund LO, Waldemar G, Wallin A, Pantoni L; LADIS Study Group. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med. 2007;167(1): 81-8.

64.        Jokinen H, Ryberg C, Kalska H, Ylikoski R, Rostrup E, Stegmann MB, Waldemar G, Madureira S, Ferro JM, van Straaten EC, Scheltens P, Barkhof F, Fazekas F, Schmidt R, Carlucci G, Pantoni L, Inzitari D, Erkinjuntti T; LADIS group. Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study. J Neurol Neurosurg Psychiatry. 2007; 78(5):491-6.  

65.        Bech-Azeddine R, Hogh P, Juhler M, Gjerris F, Waldemar G. Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting. J Neurol Neurosurg Psychiatry. 2007; 78(2):157-61.

66.        Hansen J, Svenstrup K, Ang D, Nielsen MN, Christensen JH, Gregersen N, Nielsen JE, Georgopoulos C, Bross P. A novel mutation in the HSPD1 gene in a patient with hereditary spastic paraplegia. J Neurol. 2007; 254(7):897-900.

67.        Ylikoski R, Jokinen H, Andersen P, Salonen O, Madureira S, Ferro J, Barkhof F, van der Flier W, Schmidt R, Fazekas F, Scheltens P, Waldemar G, Salvadori E, Pantoni L, Inzitari D, Erkinjuntti T. Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in Differentiating Elderly Individuals with Different Degrees of White Matter Changes. The LADIS Study. Dement Geriatr Cogn Disord. 2007; 24(2):73-81.

68.        Scheuer KH, Svenstrup K, Jennum P, Rogvi-Hansen B, Werdelin L, Fenger K, Nielsen JE. Double-blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia. Eur J Neurol. 2007; 14(6):663-6.

69.        Bruno MK, Lee HY, Auburger GW, Friedman A, Nielsen JE, Lang AE, Bertini E, Van Bogaert P, Averyanov Y, Hallett M, Gwinn-Hardy K, Sorenson B, Pandolfo M, Kwiecinski H, Servidei S, Fu YH, Ptacek L. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology. 2007; 68(21): 1782-9.

70.        Teodorczuk A, O'Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, Wahlund LO, Gouw A, Waldemar G, Schmidt R, Ferro JM, Chabriat H, Bäzner H, Inzitari D; LADIS Group. White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry. 2007;191:212-7.

71.        Holm IE, Englund E, Mackenzie IR, Johannsen P, Isaacs AM. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J Neuropathol Exp Neurol. 2007;66(10):884-91.

72.        Hansson SF, Simonsen AH, Zetterberg H, Andersen O, Haghighi S, Fagerberg I, Andreasson U, Westman-Brinkmalm A, Wallin A, Ruetschi U, Blennow K. Cystatin C in cerebrospinal fluid and multiple sclerosis. Ann Neurol. 2007; 62(2):193-6.

73.        Björkqvist M, Leavitt BR, Nielsen JE, Landwehrmeyer B, Ecker D, Hayden MR, Mulder H, Brundin P, Petersén Å. Cocaine and amphetamine regulated transcript is increased in Huntington disease. Movement Disorders 2007; 22(13):1952-4.

74.        Sjöstrand K, Rostrup E, Ryberg C, Larsen R, Studholme C, Baezner H, Ferro J, Fazekas F, Pantoni L, Inzitari D, Waldemar G; LADIS Study Group. Sparse decomposition and modeling of anatomical shape variation. IEEE Trans Med Imaging. 2007; 26(12):1625-35.

75.        Verdelho A, Madureira S, Ferro JM, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Pantoni L, Salvadori E, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D; LADIS Study.  Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry. 2007;78:1325-30.

76.        Asmus F, Hjermind LE, Dupont E, Wagenstaller J, Haberlandt E, Munz M, Strom TM, Gasser T Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical presentation. Brain 2007;130:2736-45.

77.        Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Hennerici MG. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008; 70 (12):935-942

78.        Brandt C, Bahl JC, Heegaard NH, Waldemar G, Johannsen P. Usability of Cerebrospinal Fluid Biomarkers in a Tertiary Memory Clinic. Dement.Geriatr.Cogn Disord. 2008; 25 (6):553-558

79.        Danielsen ER, Elberling TV, Rasmussen AK, Dock J, Hording M, Perrild H, Waldemar G, Feldt-Rasmussen U, Thomsen C. Reduced parietooccipital white matter glutamine measured by proton magnetic resonance spectroscopy in treated graves' disease patients. J Clin.Endocrinol.Metab 2008; 93 (8):3192-3198

80.        Dyrby TB, Rostrup E, Baare WF, van Straaten EC, Barkhof F, Vrenken H, Ropele S, Schmidt R, Erkinjuntti T, Wahlund LO, Pantoni L, Inzitari D, Paulson OB, Hansen LK, Waldemar G. Segmentation of age-related white matter changes in a clinical multi-center study. Neuroimage. 2008; 41 (2):335-345

81.        Ellefsen B, Holm-Pedersen P, Morse DE, Schroll M, Andersen BB, Waldemar G. Caries prevalence in older persons with and without dementia. J.Am.Geriatr.Soc. 2008; 56 (1):59-67

82.        Frisoni GB, Henneman WJ, Weiner MW, Scheltens P, Vellas B, Reynish E, Hudecova J, Hampel H, Burger K, Blennow K, Waldemar G, Johannsen P, Wahlund LO, Zito G, Rossini PM, Winblad B, Barkhof F. The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimers.Dement. 2008; 4 (4):255-264

83.        Frokjaer VG, Mortensen EL, Nielsen FA, Haugbol S, Pinborg LH, Adams KH, Svarer C, Hasselbalch SG, Holm S, Paulson OB, Knudsen GM. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol.Psychiatry 2008; 63 (6):569-576

84.        Gouw AA, van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Scheltens P, Barkhof F. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008; 39 (5):1414-1420

85.        Gouw AA, van der Flier WM, van Straaten EC, Pantoni L, Bastos-Leite AJ, Inzitari D, Erkinjuntti T, Wahlund LO, Ryberg C, Schmidt R, Fazekas F, Scheltens P, Barkhof F. Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc.Dis. 2008; 25 (3):247-253

86.        Gouw AA, van der Flier WM, Pantoni L, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Fazekas F, Scheltens P, Barkhof F. On the etiology of incident brain lacunes: longitudinal observations from the LADIS study. Stroke 2008; 39 (11):3083-3085

87.        Miranda B, Madureira S, Verdelho A, Ferro J, Pantoni L, Salvadori E, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitarion D. Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes. J.Neurol.Neurosurg.Psychiatry 2008; 79 (8):869-873

88.        Olde Rikkert MG, van d, V, Burns A, Dekkers W, Robert P, Sartorius N, Selmes J, Stoppe G, Vernooij-Dassen M, Waldemar G. Consensus Statement on Genetic Research in Dementia. Am.J.Alzheimers.Dis.Other Demen. 2008; 23 (3):262-266

89.        Poggesi A, Pracucci G, Chabriat H, Erkinjuntti T, Fazekas F, Verdelho A, Hennerici M, Langhorne P, O'Brien J, Scheltens P, Visser MC, Crisby M, Waldemar G, Wallin A, Inzitari D, Pantoni L. Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study. J.Am.Geriatr.Soc. 2008; 56 (9):1638-1643

90.        Winblad B, Frisoni GB, Frolich L, Johannsen P, Johansson G, Kehoe P, Lovestone S, Olde-Rikkert M, Reynish E, Visser PJ, Vellas B. Editorial: EADC (European Alzheimer Disease Consortium) Recommendations for Future Alzheimer Disease Research in Europe. J.Nutr.Health Aging 2008; 12 (10):683-684

BØGER & BOGKAPITLER

1.            Gade, A. Neuropsykologi. Den store danske encyklopædi. København: Danmarks Nationalleksikon, 1999:14:128-129 (bogkapitel).  

2.            Waldemar G. Outcome measures and ethical issues in the pharmacotherapy of Alzheimer’s disease. World Psychiatry Association (WPA): Evidence & Experience in Psychiatry - dementia.  John Wiley & Sons Ltd. 2000; 249-252.

3.            Fox NC, Scahill RI, Høgh P, Rossor MN. Structural and Functional Imaging in Alzheimer’s disease. In: Dawborn D, Allen SJ, eds. Neurobiology of Alzheimer’s disease. Bios Scientific Publishers 2001 (bogkapitel). 

4.            Waldemar G, Winblad B, Engedal K, Soininen H, Verhey F, Wimo A, Wetterholm AL, Zhang R, Haglund A, Subbiah P, and the Donepezil Nordic Study Group. Benefits of donepezil on cognition, function and/or neuropsychiatric symptoms in patients with both mild and moderate Alzheimer’s disease over one year. In: Iqbal K, Sisodia SS, Winblad B, eds.: Alzheimer’s disease: Advances in etiology, pathogenesis and therapeutics. John Wiley & Sons, Ltd., UK, 2001, 725-738 (bogkapitel).

5.            Hejl A, Høgh P, Waldemar G. Potentially  reversible conditions in memory clinic patients. In Iqbal K, Sisodia SS, Winblad B, eds.: Alzheimer's disease: Advances in etiology, pathogenesis and therapeutics. John Wiley & Sons, Ltd., London, U.K., 2001, 123-128 (bogkapitel). 

6.            Waldemar G, Dubois B, Emre M, Scheltens P, Tariska P, Rossor M. Diagnosis and management of Alzheimer’s disease and related disorders: The role of neurologists in Europe. In: Martinez Lage, Hachinski V, eds. Envejemiento cerebral y enfermedad, Editorial Triacastela, Madrid, Spain, 2001, chapter 11, 185-205 (bogkapitel).

7.            Wahlund LO, Basun H, Waldemar G. Reversible or arrestable dementias. In: Qizilbash N, Schneider L, Chui H, Tariot P, Brodaty H, Kaye J, Erkinjuntti T, eds. Evidence-based dementia practice. Blackwell Science Publishing, Oxford, U.K. 2002; 330-340 (bogkapitel).

8.            Brandt Å, Pedersen EF, Sørensen LV. Forskning i sundhedsfremme og sygdomsforebyggelse, herunder arbejdsmiljø. I: Borg T, Runge U, Tjørnov J, red. Basisbog i ergoterapi. København: Munksgaard 2003:543-563. (bogkapitel)

9.            Hjortbak E, Jacobsen A, Sørensen LV. At muliggøre aktivitet og deltagelse i forbindelse med primær kommunal rehabilitering og individrettet forebyggelse - især blandt ældre. I: Borg T, Runge U, Tjørnov J, red. Basisbog i ergoterapi.  København: Munksgaard 2003:429-450. (bogkapitel)

10.        Buss DV. Værgemål og andre former for repræsentation. Nyt Juridisk Forlag. 2. udgave. 2003:1-168 (bog).

11.        Waldemar G, Vellas B. Memantine in moderate to severe Alzheimer’s disease. In: Research and practice in Alzheimer’s disease, Vol. 8: Severe dementia. Serdi Publishers, Paris, 2003; 83-92.

12.        Waldemar G. Demenssygdomme. I: Paulson OB, Gjerris F, Sørensen PS, red. Klinisk neurologi og neurokirurgi. København: FADLs Forlag; 4. udg., 2004:483-96..

13.        Waldemar G. Opfattelsen af demens de sidste 100 år. I: Thage O, Engelbrecht N, Hasselbalch S, red. Forstå demens. København: Lindhardt og Ringhof; 2004:8-13 (bogkapitel).

14.        Buss DV. Retsstillingen ved demens. I: Thage O, Engelbrecht N, Hasselbalch S, red. Forstå demens. København: Lindhardt og Ringhof; 2004:204-216 (bogkapitel).

15.        Gade A, Bruhn P. Neuropsykologiske dysfunktioner. I: Paulson OB, Gjerris F, Sørensen PS, red. Klinisk neurologi og neurokirurgi. København: FADLs Forlag; 4. udg., 2004:133-162 (bogkapitel)

16.        Hasselbalch SG, Engelbrecht N, Thage O, red. Forstå demens. Lindhardt og Ringhof, København, 2004:1-240 (bog).

17.        Hasselbalch SG, Gramkow M. Undersøgelse for demens. I: Thage O, Engelbrecht N, Hasselbalch S, red. Forstå demens. København: Lindhardt og Ringhof; 2004:125-42 (bogkapitel).

18.        Hasselbalch SG, Stokholm J. Demenssygdomme. I: Thage O, Engelbrecht N, Hasselbalch S, red. Forstå demens. København: Lindhardt og Ringhof; 2004:59-95 (bogkapitel).

19.        Hørding M. Behandling af psykiatriske problemer ved demens. I: Thage O, Engelbrecht N, Hasselbalch S, red. Forstå demens. København: Lindhardt og Ringhof; 2004:155-160 (bogkapitel).

20.        Hørding M. Psykiatriske problemer ved demens. I: Thage O, Engelbrecht N, Hasselbalch S, red. Forstå demens. København: Lindhardt og Ringhof; 2004:96-102 (bogkapitel).

21.        Johannsen P. Lægemidler mod demens. I: Thage O, Engelbrecht N, Hasselbalch S, red. Forstå demens. København: Lindhardt og Ringhof; 2004:147-54 (bogkapitel).

22.        Nielsen JE. Er demens arvelig ? I: Thage O, Engelbrecht N, Hasselbalch S, red. Forstå demens. København: Lindhardt og Ringhof;2004:109-15 (bogkapitel).

23.        Lauridsen I, Eckermann A. At mestre demens. I: Thage O, Engelbrecht N, Hasselbalch S, red. Forstå demens. København: Lindhardt og Ringhof; 2004:161-184 (bogkapitel).

24.        Albert H, Hovmand B, Lund H, Winkel A,  Sørensen LV. Case rapport. En grundbog i praksisformidling. Munksgaard Danmark, København 2005 (bog).

25.        Thellefsen T, Sørensen LV. Case study 2: Vidensprofilering af et ikke-videnskabeligt vidensdomæne: Dansk ergoterapi.I: Thellefsen T. Vidensprofilering. Aalborg Universitetsforlag 2005 s. 68-73 (bogkapitel).

26.        Burns A., Ballard C, Banerjee S, Calabrese P, de Deyn PP, Grossberg G, Jones R, Sandman PO, Selmes J, Vellas B, Waldemar G, Wilcock G, Winblad B, Zaudig M. The clinical use of Memantine. In: Vellas B, et al., eds., Research and Practice in Alzheimer’s Disease, vol. 10, Serdi Publishers, Paris, France, 2005; 205-220.

27.        Waldemar G. Neurology. In: Burns A., ed., Standards in Dementia Care. Taylor & Francis, London, U.K. 2005; chapter 24, 179-184.

28.        Dansbo N, Hansen, JG, Waldorff FB (red). Håndbog for projektmagere i almen praksis. Fra ide til færdigt produkt. Forskningsenheden for Almen praksis i København, Center for Sundhed og Samfund. København 2005.

29.        Johannsen P, Sørensen LV. Demenssygdomme i Wæhrens E, Winkel A, Gyring J (red) Neurologi og neurorehabilitering. Munksgaard, Danmark. 2006, kapitel 13, 144-148 (bogkapitel)

30.        Sørensen LV, Johannsen P. Rehabilitering af personer med demens i Wæhrens E, Winkel A, Gyring J (red) Neurologi og neurorehabilitering. Munksgaard, Danmark. 2006, kapitel 25, side 256-262 (bogkapitel)

31.        Johannsen P. Midler mod demens i  Court Pedersen et al. (red)  Medicin.dk 2007 - Informatum, Danmark. 2006, side 387-388 (bogkapitel)

32.        Olsen RB, Carlskov I, Buss DV, Søndergaard M, Kaagaard S, Skovgaard B. Demens efteruddannelse. Munksgaard, Danmark. 2006, side 1-176 (bog)

33.        Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad. Alzheimer’s disease and other disorders associated with dementia i Hughes R, Brainin M, Gilhus NE (red) European Handbook of Neurological Management (European Federation of Neurological Societies. Blackwell Publishing 2006 side 266-298 (bogkapitel)

34.        Hasselbalch SG, Knudsen GM. Imaging of Neurotransmitter Systems in Dementia. In: Herholz K, et al. (red). The Dementias. Early Diagnosis and Evaluation, Taylor and Francis Group, New York, 2006; 253-277 (bogkapitel).

35.        Buss DV, Waldemar G. Practice of competence assessment in dementia: Denmark. I Stoppe G (red) Competence Assessement in Dementia. Springer, Wien. 2008; 107-108 (bogkapitel).

36.        Buss DV, Waldemar G. Practice of competence assessment in Dementia: Denmark. In: Stoppe G (ed.), Competence Assessment in Dementia. Germany: Springer-Verlag/Wien. 2008: 107-108

37.        Christensen HK, Hjermind LE. Neurologiske sygdomme. I Praktisk Medicin 2009, 19;126-143.

ANDRE PUBLIKATIONER

1.            Waldemar G. Ny hukommelses- og demensklinik. Tidsskrift for Dansk Sundhedsvæsen. 1995;9:374-375.

2.            Waldemar G. Demens. Lægemagasinet 1996;7:22-24.

3.            Waldemar G, Bolwig T, Paulson OB. Demens. I Sundhedsstyrelsen i samarbejde med HjerneÅret: Forebyggelse af hjernesygdomme. Statens Information, 1996, s. 34-43

4.            Mortensen H. Når hukommelsens svigter. Helse 1996;12.

5.            Waldemar G. Vedr. Marcussen et al. Demens-sjukdomar. Ugeskrift for Læger 1996;158:2276 (boganmeldelse).

6.            Jakobsen O. Demens og demensudredning på Rigshospitalet. Sygeplejersken 1997;31:24-29

7.            Waldemar G. Demens. HELSE 1997;43:60-61.

8.            Waldemar G. Demens. I: Kend din hjerne. København: Helse og HjerneÅret, 1997, 55-58.

9.            Waldemar G. Billeddiagnostik ved demens. Gerontologi og Samfund 1997;13:40-42.

10.        Dinesen O (red), Buss D, Gulmann NC, Høgh P, Jørgensen OS, Schultz-Larsen K, Frijs-Madsen B, Kragh-Sørensen P, Vass M, Waldemar G. Demens – en vejledning til praktiserende læger. København, 1.udgave 1997, 2. udgave, 1998, 3. udgave 2004 (vejledning).

11.        Waldemar G, Bruhn P, Dam AM, Hatting A, Holler M, Jakobsen J, Kragh-Sørensen P, Lykke J, Mogensen F, Nordenbo A, Thomassen AR, Thuesen E, Unden M, Vass M. Referenceprogram for demensudredning. Dansk Neurologisk Selskab, 1998 (konsensusrapport, 70 sider).

12.        Waldemar G. Imaging techniques in dementia. The News 1998;6-7.

13.        H:S Sundhedsfaglige Råd for Neurologi, arbejdsgruppe om demens Waldemar G (formand), Bülow LB, Dam AM, Hasselbalch E, Jønsson A, Kongstad L, Kraglund E, Mahneke T, Polonius I, Rosenbeck-Hansen J, Schultz-Larsen K, Sørensen PS. Diagnostik og behandling af demens i H:S området, 1998 (konsensusrapport, 27 sider).

14.        Waldemar G. Ny viden om demens. Forlaget Helse, København, 1998 (informationsbrochure, 20 sider)

15.        Waldemar G. Demens og Alzheimers sygdom. Praksissektoren 1998;2:22-24.

16.        Waldemar G, Jakobsen J. En protest og to forslag. Ugeskrift for Læger 1998;160:5679-5680 (korrespondence).

17.        Gade A. Sanserne og oplevelsen af det sansede. Hjerneforum, 1998;1:9-18.

18.        Waldemar G. Demenssygdomme hos ældre. I: Ældre & demens, depression & selvmord. Ældreforum, København, 1999, 16-21.

19.        Waldemar G. Hukommelsesklinikken på Rigshospitalet. Nyt fra Alzheimerforeningen på Frederiksberg1999;1(2):6-7.

20.        Waldemar G. Demens. I: Patientvejledningen. Nyt Nordisk Forlag Arnold Busck, København, 1999:16 (nye udgaver 2000, 2002, og 2004) (håndbog og CD for praktiserende læger).

21.        Hasselbalch, SG. Medicinsk behandling af Alzheimers sygdom. Lægemagasinet for Praktiserende Læger, 1999

22.        Waldemar G. Demenssygdomme hos ældre. Ældrenetværket 2000;3:3-6.

23.        Waldemar G, Lunn I. Verdenskongres om Alzheimers sygdom – håb om nye muligheder for behandling. Alzheimerforeningens Magasin, 2000 (3):6-7,

24.        Waldemar G, Bruhn P. Demens. I: Therkelsen J, red: Dansk Neurologisk Selskab 1900-2000. Festskrift. Lægeforeningens Forlag. København, 2000, pp.165-170.

25.        Waldemar G. Hughes RAS and Perkin GD, eds. Neurology and medicine. Ugeskrift for Læger 2000;162:2061 (boganmeldelse).

26.        Waldemar G. Rubak J et al., eds. Klinisk vejledning i demens. DSAM. Ugeskrift for Læger 2000;162:2867 (boganmeldelse).

27.        Waldemar G, Eckermann A. Tidlig diagnostik og opfølgning ved demens. Gerontologi og Samfund 2000;16:82-84.

28.        Eckermann A. Rigshospitalets Hukommelsesklinik - støtte til pårørende. Nyt fra   Alzheimerforeningen på Frederiksberg 2000;2:1-2.

29.        Waldemar G. Insights into dementia diagnosis and management. Medscape Neurology 2000 (internet tidsskrift) www.medscape.com/medscape/CNO/2000/EFNS

30.        Waldemar G. New perspectives in dementia. Medscape Neurology 2001 (internet tidsskrift) www.medscape.com/CNO/2001/WCNCME

31.        Waldemar G. Demens – nye muligheder for professionelle og frivillige. I: Nye demensinitiativer. København. Socialministeriet, 2001, pp 7-9.

32.        Waldemar G. Behandling af demens – 10 år frem og 10 år tilbage. Alzheimerforeningens Magasin 2001 (1):7

33.        Waldemar G. Vaccine mod Alzheimers sygdom – fup eller fakta ? Alzheimerforeningens Magasin 2001 (1):7-9.

34.        Hasselbalch S. Medicinsk behandling af Alzheimers sygdom – status og perspektiver. Lægemagasinet for praktiserende læger 2001:2.

35.        Hasselbalch S. SPECT skanning ved demensudredning. Demens 2001; 1, 21-24.

36.        Waldemar G. Viden om demenssygdomme. Hvordan stilles diagnosen ? Behandlingsmuligheder. Alzheimers sygdom. www.alzheimer.dk 2001 (internetopslag).

37.        Lauridsen A., Sørensen H. Glemmer du, så husker vi! Udviklingsaktiviteter – sygepleje. Sygeplejesymposium, Rigshospitalet, 2001, 37-40

38.        Jakobsen O. Opsøgende hjemmebesøg af demenssygeplejerske – det første møde mellem sygeplejersken og den henviste patient. Udviklingsaktiviteter – sygepleje. Sygeplejesymposium, Rigshospitalet, 2001, 103-107.

39.        Sundhedsstyrelsens arbejdsgruppe vedrørende demens (Waldemar G medlem): Sundhedsstyrelsen. Demens – den fremtidige tilrettelæggelse af sundhedsvæsenets  indsats vedrørende diagnostik og behandling.  Sundhedsstyrelsen 2001, pp 1-140.

40.        Projektgruppe vedrørende udarbejdelse af MTV om CT skanning ved demens-udredning. (Hasselbalch S medlem). Anvendelse af billeddiagnostik ved demensudredning. En medicinsk teknologivurdering. www.cemtv.dk, 2001 (mtv rapport, 80 sider).

41.        Waldemar G. Demens. Alzheimers sygdom. www.sundhed.dk, 2001-2002 (internetopslag)

42.        Waldemar G. Research refines our understanding of the non-Alzheimer dementias. Medscape Neurology (internet tidsskrift) 2002: www.medscape.com/medscape/CNO/2002

43.        Waldemar G. Velfungerende demente med Alzheimer diagnose. Alzheimerforeningens Magasin 2002 (1):16.

44.        Waldemar G. Forord i: Alzheimer’s disease resource handbook. Lundbeck 2002.

45.        Alzheimers sygdom og demens. CD Rom : ”Information til personer med demens og deres pårørende.” Formidlingscenter Nord, 2002.

46.        Hasselbalch S. Primære demenssygdomme. Lægemagasinet for praktiserende læger 2002:2, 18-23.

47.        Pinner M, Borgesen SE, Jensen R, Birket-Smith M, Gade A, Riis JO. Konsensusrapport om commotio cerebri (hjernerystelse) og det postcommotionelle syndrom. Stouby: Videnscenter for Hjerneskade; 2003:1-82 (konsensusrapport).

48.        Elberling TV, Stokholm J, Hogh P, Waldemar G. Common causes of cognitive symptoms in young and middle-aged adults referred to memory clinics. Clinicican’s research digest 2003;21:2 (Summary).

49.        Hejl A-M, Waldemar G. Reversible dementias. J Neurol Neurosurg Psychiatry 2003; 74:1008 (letter, correspondence)

50.        Eckermann A. DAISY, Danish Alzheimer Intervention StudY. Nyhedsbrevet for demenskoordinatorer i Danmark; 2003:7.

51.        Eckermann A. Stort udviklingsprojekt er godt i gang. DAISY, Danish Alzheimer Intervention StudY. Alzheimerforeningens Magasin; 2003:3.

52.        Waldemar G. Om Alzheimers sygdom. HELSE 2003; 8:38-40.

53.        Waldemar G. Information om behandling med Reminyl ved Alzheimers sygdom. Vejledning til patienter og pårørende  udgivet af Janssen-Cilag A/S 2003 (informationshæfte).

54.        Hasselbalch SG. Demens. Pfizer Plus 2003 (temahæfte).

55.        Waldemar G. Skausig OB, Eckermann A. Demens – Viden der er værd at huske. Lundbeck Pharma 2003;1-28.

56.        Waldemar G. DemensDagene 2004 – en tværfaglig konference om demens. Magasin om Alzheimers og andre demenssygdomme, Alzheimerforeningen, 2004;14(1):14.

57.        Waldemar G. Nye tilbud til demente. Magasinet Demens. Alzheimerforeningen, 2004;14(4):10-1.

58.        Gade A. Alzheimers sygdom; demens; dissemineret sklerose; frontotemporal demens; narkolepsi; psykokirurgi; Retts syndrom; syfilis; Tourette syndrom; Wernicke-Korsakoff sygdom (o.a. lign. opslag). I: Bjerg J (red.). Gads psykologileksikon. København, Gads Forlag 2004.

59.        Gade A, Bruhn P (2004). Afasi; amnestisk syndrom; anosognosi; apraksi; neglekt. I: Bjerg J (red.). Gads psykologileksikon. København, Gads Forlag 2004.

60.        Johannsen P. Demente på plejecentre – kan det betale sig at udrede og behandle. Neurohow. Forum for Læger 2004;12:11-12.

61.        Waldemar G. Vitamin-B12 mangel og demens. Ugeskr Læger 2004;166; 1581-2 (korrespondence).

62.        Johannsen P, Abelskov KE, Almar K, Christensen PH, Hasselbalch SG, Laugesen LP, Hansen FR, Skausig OB. Er medicinsk Alzheimer behandling uden virkning? Ugeskr Læger 2004;166:2916-8 (korrespondence)

63.        Hasselbalch SG. Imaging markers in dementia. The Lundbeck Institute Magazine 2004;12-6.

64.        Hasselbalch SG. Demens eller Alzheimers ? Magasin om Alzheimers og andre demenssygdomme, Alzheimerforeningen, 2004;14(1):15-6.

65.        Hørding M. Søvnforstyrrelser ved demens. Hospital – Health Care, 2004: 3, 4-5.

66.        Hørding M. Søvnforstyrrelser ved demens. Lægemagasinet for praktiserende læger, 2004: 4, 4-6.

67.        Johannsen P. Demente på plejecentre – kan det betale sig at udrede og behandle? Nerohow. Forum for læger: 2004: 12, 11-12.

68.        Waldemar G, Brændgård H, Buss DV, Hansen FR, Hasselbalch S, Lolk A. Demens (Interaktiv undervisningsmanual og CD for praktiserende læger). Helix Communications 2005.

69.        Eckermann A. Informationsmateriale - råd og oplysning til demente og pårørende. Til brug for Demensnet, september 2005 www.demensnet.dk

70.        Eckermann A. DAISY - et interventionsstudie målrettet nydiagnosticerede demente tidligt i sygdomsforløbet. Udviklingsaktiviteter Sygepleje – Rigshospitalet 2005

71.        Rishøj S. Projektsygeplejersken sikrer sammenhængen. Sygeplejersken 2005;6:38-40.    

72.        Buss D. Juridisk informationsmateriale til demente og pårørende til brug for Demensnet, september 2005

73.        Hasselbalch S. Demente i praksis. Læge-Helse nr. 9; 2005: 14-17.

74.        Hasselbalch S.Imaging Markers in Dementia. CNS Forum E-Magazine;17.08 2005.

75.        Hasselbalch S. Er Alzheimers sygdom en livstilssygdom? Magasinet Demens nr. 2, 2005: 12-14.

76.        Hasselbalch S. Demensudredning på en specialiseret klinik. Magasinet Demens nr. 2, 2005:

77.        Waldorff FB, Eriksson, T. Praksisdeklarationsgruppen [Konsulentrapport]. Det Danske Kvalitetsprojekt (DAK), Juni 2005.

78.        Waldorff FB, Eriksson T. Måling af kvalitet i almen praksis. Practicus 2005; 173:36-38.

79.        Waldorff, FB. Brug af kognitive tests ved demensudredning i almen praksis. DemensKoordinatorer i Danmark. Nyhedsbrev nr 3, September 2005.

80.        Eckermann A., Hasselbalch S. og Skjøtt K. ”Ide-katalog - du kan gøre en forskel!” Inspiration og metode til at hverve gymnasieelever til frivilligt arbejde gennem formidling om demens. For Alzheimerforeningen 2005/06.

81.        Buss DV. Hvilke ønsker har demente til fremtiden. Tidsskrift for Familie- og Arveret 2007; 2: 175-182.

82.        Baungård L, Jensen EM, Poulsen B, Jepsen D, Rishøj S, Forebyggende besøg. Glem ikke hukommelsen. Sygeplejersken 2007; 11: 49-52.

83.        Skovgaard B, Andersen BB. Samarbejde om demens  - erfaringer fra det tidligere H:S, København og Frederiksberg kommuner. Læger i Hovedstadsregionen 2007;4: 26-28

84.        Hjermind LE. Parkinson's sygdom en sygdom man arver ? NeuroHow 2007;15:8-15

85.        Hasselbalch SG. Demens skal behandles. Best Practice 2007, 2: 14.

86.        Johannsen P. Medicinsk behandling af demens. Best Practice 2007, 2: 16.

87.        Sundhedsstyrelsen, Jensen, L. K., Vestergaard, K., Waldemar, G., Skejø, P., Lolk, A., Larsen, V. A., Stokholm, J., van der Mark, S., Kørner, A., Olsen, J., Lee, A., Hansen, F. R., Krogh, L. N., Hulgaard, H., and Andersen, S. E. Udredning og behandling af demens - en medicinsk teknologivurdering. Bech, K., Hansen, K., Mortensen, B. B., and Nielsen, C. P.  8-5-2008. København, Sundhedsstyrelsen. (GENERIC)
Ref Type: Report

88.        Baungård, L., Elbrønd, M., and Rishøj, S. Glem ikke .... Idekatalog til indsatsen over for borgere med demens.  1-31. 2008.  Sygekasserne Helsefond, Styrelsen for Social Service, Ikast Kommune. (GENERIC)

89.        Dystoni - en bevægeforstyrrelse. Hjermind L, Dupont E, Spangsberg M, Poulsen UB (red). Dansk dystoniforening.

90.        Skovgaard B, Andersen BB. Samarbejde om demens - erfaringer fra det tidligere H:S, København og Frederiksberg Kommuner. Lægen i Hovedstadsregionen 2008; 4:26-28

91.        Waldemar, G. Demens. Alzheimers sygdom. Sundhed.dk 2008. 2008. (GENERIC)
Ref Type: Magazine Article

92.        Waldemar G. Demens. In: Christensen B (ed.), Patientvejledningen. København: Nyt Nordisk Forlag Arnohld Busck A/S. 2008: 235-236